Celgene CorpAdd to My Watchlist

CELG:USNASDAQ GSIndustry: Medical-Biomedical/Gene
  • 118.08
  • 5.96  -4.80%
    Today's Change
  • 124.04
    Previous Close
  • Today
    52 Week Low - High
5:20 pm ET 8/31/2015
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding791 million
Market Cap$93 billion
Return on Equity ttm39.34%
Last DividendCELG:US does not pay a dividend
EPS: Year Actual ttm2.763
EPS: Year Est. 12/15 ttm4.798
EPS: Quarterly Actual 6/15 1.23
EPS: Quarterly Est. 9/15 1.21
Price/Earnings ttm42.73
Relative Price/Earnings--
Earnings Growth Rate42.29
Company Description
Celgene Corporation is a global biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of therapies designed to treat cancer and immune-inflammatory related diseases.
Revenue$8 billion
Net Income$2 billion
Total Assets$17 billion
Web Sitewww.celgene.com

Latest Headlines


Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

Sign In Now


Not Registered?

Get complete access to The Washington Post online - it's FREE!